Pitel, Beth A. http://orcid.org/0000-0002-5138-824X
Zepeda-Mendoza, Cinthya
Sachs, Zohar http://orcid.org/0000-0001-9386-4163
Tang, Hongwei
Shivaram, Suganti
Sharma, Neeraj http://orcid.org/0000-0002-8229-3083
Smadbeck, James B.
Smoley, Stephanie A.
Pearce, Kathryn E.
Luoma, Ivy M.
Cook, Joselle http://orcid.org/0000-0001-5335-9533
Litzow, Mark R. http://orcid.org/0000-0002-9816-6302
Hoppman, Nicole L.
Viswanatha, David
Xu, Xinjie
Ketterling, Rhett P.
Greipp, Patricia T. http://orcid.org/0000-0002-5536-9011
Peterson, Jess F. http://orcid.org/0000-0003-2496-8000
Baughn, Linda B. http://orcid.org/0000-0001-5229-4897
Article History
Received: 24 May 2023
Revised: 7 August 2023
Accepted: 24 August 2023
First Online: 6 September 2023
Competing interests
: LBB serves as consultant for Genentech, XX serves as consult for Kura Oncology, PTG serves as consultant for AbbVie and BP sits on the Qiagen Somatic Advisory Board. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The work was performed using funds from the Mayo Clinic Department of Laboratory Medicine and Pathology.